In vivo research demonstrates higher soluble TREM2 levels in AD cerebrospinal fluid and plasma compared to age-matched samples, though unlike in vitro studies, no detectable differences were found in TNF-α and IL-6 levels between the two groups [151]. This evidence concerns the gene TNF and Alzheimer disease.